Oral HIV pre-exposure prophylaxis use and resistance-associated mutations among men who have sex with men and transgender persons newly diagnosed with HIV in the Netherlands: results from the ATHENA cohort, 2018 to 2022.

doi:10.2807/1560-7917.ES.2024.29.38.2400083

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Oral HIV pre-exposure prophylaxis use and resistance-associated mutations among men who have sex with men and transgender persons newly diagnosed with HIV in the Netherlands: results from the ATHENA cohort, 2018 to 2022.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin - 1 Sept 2024

Jongen Vita W, Bezemer Daniela, van Sighem Ard, Boyd Anders, Rokx Casper, Grintjes Karin, Cents-Bosma Aafke, Op de Coul Eline, van Benthem Birgit, Wensing Annemarie, Wit Ferdinand Wnm, van der Valk Marc

Abstract excerpt

BackgroundIn the Netherlands, HIV pre-exposure prophylaxis (PrEP) has been available since 2019. However, the extent of PrEP use prior to HIV diagnosis and development of PrEP-resistance-associated mutations (RAMs) is not known.AimWe assessed prior PrEP use and potential transmission of PrEP RAMs among men who have sex with men (MSM) and transgender persons (TGP) with a new HIV diagnosis in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Drug Resistance, Viral

Share to HIV-1

Share to HIV Infections

Share to Homosexuality, Male

Share to Mutation

Share to Netherlands

Source

Open in PubMed Open full text

Identifiers

PMID: 39301743
DOI: 10.2807/1560-7917.ES.2024.29.38.2400083
PMCID: PMC11484289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oral HIV pre-exposure prophylaxis use and resistance-associated mutations among men who have sex with men and transgender persons newly diagnosed with HIV in the Netherlands: results from the ATHENA cohort, 2018 to 2022.PMID 39301743Read ↗

Oral Pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populationsSemantic proximity Read ↗

Pre-exposure Prophylaxis Use History in People With Antiretroviral Resistance at HIV Diagnosis: Findings From New York City HIV Surveillance and Partner Services, 2015-2022.Semantic proximity Read ↗

Low clinical impact of HIV drug resistance mutations in oral pre-exposure prophylaxis: a systematic review and meta-analysis.Semantic proximity Read ↗

High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.Semantic proximity Read ↗

Low retention on PrEP and barriers to PrEP use among key populations in Kinshasa, DRC: a mixed method studySemantic proximity Read ↗

Effect of pre-exposure prophylaxis on risky sexual behaviour of female sex workers in Dakar, Senegal: A randomised controlled trialSemantic proximity Read ↗

Considerations of HIV PrEP Among Heterosexually Active Women and Men: Results from a Qualitative Study in New York CitySemantic proximity Read ↗

Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database.Semantic proximity Read ↗

HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru.Semantic proximity Read ↗

HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.Semantic proximity Read ↗

Improving HIV pre-exposure prophylaxis (PrEP) adherence and retention in care: Recommendation development from a national PrEP programmeSemantic proximity Read ↗

Brief Report: Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.